Related Experiment Video
Updated: Aug 15, 2026

Isolation of Labile Multi-protein Complexes by in vivo Controlled Cellular Cross-Linking and Immuno-magnetic Affinity Chromatography
Published on: March 10, 2010
Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction
M Leinonen1, E Linnanmäki, K Mattila
1National Public Health Institute, Helsinki, Finland.
Insights
This study found chlamydial lipopolysaccharide-specific immune complexes in 57% of acute myocardial infarction patients, suggesting a link between chronic chlamydial infection and heart attacks.
Area of Science:
- Cardiology
- Immunology
- Infectious Diseases
Background:
- Cardiovascular diseases, including acute myocardial infarction (AMI), represent a significant global health burden.
- Emerging research suggests infectious agents may play a role in the pathogenesis of atherosclerosis and AMI.
- Chlamydia pneumoniae is a potential etiological agent implicated in cardiovascular disease.
Purpose of the Study:
- To investigate the presence of chlamydial lipopolysaccharide (LPS)-specific immune complexes (IC) in patients with acute myocardial infarction (AMI).
- To determine if chlamydial LPS-specific IC are associated with AMI compared to control groups.
Main Methods:
- Paired serum samples from 44 AMI patients and 44 matched random controls were analyzed.
- Two detection methods specific for chlamydial LPS were employed to identify circulating IC.
- Serum samples from 29 patients with known IC-associated diseases served as specificity controls.
Main Results:
- Chlamydial LPS-specific immune complexes were detected in 57% of AMI patients.
- In contrast, only 12% of random controls and 10% of patient controls tested positive for these IC.
- The difference in detection rates was statistically significant (P < 0.0001).
Conclusions:
- The high prevalence of chlamydial LPS-specific IC in AMI patients suggests a potential association between chronic chlamydial infection and acute myocardial infarction.
- These findings warrant further investigation into the role of Chlamydia pneumoniae in cardiovascular disease development.
Abstract:
The presence of circulating immune complexes (IC) was studied using two detection methods specific for chlamydial lipopolysaccharide (LPS) in paired serum samples of 44 patients (30 men and 14 women) with acute myocardial infarction (AMI). Forty-four random controls were individually matched for locality, age and sex with the AMI patients. As specificity controls for the IC assays single serum samples from 29 patients with diseases characterized by the presence of circulating IC were used. Fifty-seven per cent of AMI patients, 12% of their random controls and 10% of the patient controls were shown to have chlamydial LPS-specific immune complexes in their sera (P less than 0.0001, AMI versus random and patient controls). This finding provides further evidence of the possible association of chronic chlamydial infection with AMI.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
06:38Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
Published on: September 26, 2025
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Hypersensitivity Reactions: Immune-Complex Reactions